250 related articles for article (PubMed ID: 23272512)
1. Non-alcoholic fatty liver disease is associated with cardiovascular risk factors of metabolic syndrome.
Hurjui DM; Niţă O; Graur LI; Mihalache L; Popescu DS; Huţanaşu IC; Ungureanu D; Graur M
Rev Med Chir Soc Med Nat Iasi; 2012; 116(3):692-9. PubMed ID: 23272512
[TBL] [Abstract][Full Text] [Related]
2. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
[TBL] [Abstract][Full Text] [Related]
3. Association of uric acid levels with components of metabolic syndrome and non-alcoholic fatty liver disease in overweight or obese children and adolescents.
Cardoso AS; Gonzaga NC; Medeiros CC; Carvalho DF
J Pediatr (Rio J); 2013; 89(4):412-8. PubMed ID: 23791233
[TBL] [Abstract][Full Text] [Related]
4. Association of nonalcoholic fatty liver disease with components of metabolic syndrome according to body mass index in Korean adults.
Kwon YM; Oh SW; Hwang SS; Lee C; Kwon H; Chung GE
Am J Gastroenterol; 2012 Dec; 107(12):1852-8. PubMed ID: 23032980
[TBL] [Abstract][Full Text] [Related]
5. Presence of the metabolic syndrome in obese adolescents predicts impaired glucose tolerance and nonalcoholic fatty liver disease.
Love-Osborne KA; Nadeau KJ; Sheeder J; Fenton LZ; Zeitler P
J Adolesc Health; 2008 Jun; 42(6):543-8. PubMed ID: 18486862
[TBL] [Abstract][Full Text] [Related]
6. The association of metabolic syndrome, insulin resistance and non-alcoholic fatty liver disease in overweight/obese children.
El-Koofy NM; Anwar GM; El-Raziky MS; El-Hennawy AM; El-Mougy FM; El-Karaksy HM; Hassanin FM; Helmy HM
Saudi J Gastroenterol; 2012; 18(1):44-9. PubMed ID: 22249092
[TBL] [Abstract][Full Text] [Related]
7. Association of age and sex with cardiovascular risk factors and insulin sensitivity in overweight children and adolescents.
Koenigsberg J; Boyd GS; Gidding SS; Hassink SG; Falkner B
J Cardiometab Syndr; 2006; 1(4):253-8. PubMed ID: 17679813
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular risk factors and the metabolic syndrome in pediatric nonalcoholic fatty liver disease.
Schwimmer JB; Pardee PE; Lavine JE; Blumkin AK; Cook S
Circulation; 2008 Jul; 118(3):277-83. PubMed ID: 18591439
[TBL] [Abstract][Full Text] [Related]
9. Association of adiponectin with hepatic steatosis: a study of 1,349 subjects in a random population sample.
Flechtner-Mors M; George SN; Oeztuerk S; Haenle MM; Koenig W; Imhof A; Boehm BO; Graeter T; Mason RA; Kratzer W; Akinli AS;
BMC Res Notes; 2014 Apr; 7():207. PubMed ID: 24693952
[TBL] [Abstract][Full Text] [Related]
10. Relation of uric acid to serum levels of high-sensitivity C-reactive protein, triglycerides, and high-density lipoprotein cholesterol and to hepatic steatosis.
Keenan T; Blaha MJ; Nasir K; Silverman MG; Tota-Maharaj R; Carvalho JA; Conceição RD; Blumenthal RS; Santos RD
Am J Cardiol; 2012 Dec; 110(12):1787-92. PubMed ID: 22975466
[TBL] [Abstract][Full Text] [Related]
11. Study of impaired glucose tolerance, dyslipidemia, metabolic syndrome, and cardiovascular risk in a south Indian population.
Martha S; Ramreddy S; Pantam N
J Postgrad Med; 2011; 57(1):4-8. PubMed ID: 21206129
[TBL] [Abstract][Full Text] [Related]
12. 1h Post-load Blood Glucose in the Identification of Proatherogenic Cardiometabolic Profile in Obesity.
Popovic DS; Tomic-Naglic D; Mitrovic M; Zivanovic Z; Vukovic B; Stokic E
Endocr Metab Immune Disord Drug Targets; 2017; 17(3):226-237. PubMed ID: 28641570
[TBL] [Abstract][Full Text] [Related]
13. The hypertriglyceridemic waist phenotype is associated with fatty liver and glycometabolic profiles in overweight and obese adults: a cross-sectional study.
Zhou M; Li F; Tang H; Wu S; Meng L; Dong Y; Wang F; Quach B; Yang Y; Ma J; Baker JS
Sci Rep; 2022 Feb; 12(1):2410. PubMed ID: 35165286
[TBL] [Abstract][Full Text] [Related]
14. Associations Between Serum Uric Acid Concentrations and Cardiometabolic Risk and Renal Injury in Obese and Overweight Children.
Özalp Kızılay D; Şen S; Ersoy B
J Clin Res Pediatr Endocrinol; 2019 Sep; 11(3):262-269. PubMed ID: 30759960
[TBL] [Abstract][Full Text] [Related]
15. Metabolic syndrome in childhood from impaired carbohydrate metabolism to nonalcoholic fatty liver disease.
Manco M
J Am Coll Nutr; 2011 Oct; 30(5):295-303. PubMed ID: 22081615
[TBL] [Abstract][Full Text] [Related]
16. Hepatic steatosis, obesity, and the metabolic syndrome are independently and additively associated with increased systemic inflammation.
Ndumele CE; Nasir K; Conceiçao RD; Carvalho JA; Blumenthal RS; Santos RD
Arterioscler Thromb Vasc Biol; 2011 Aug; 31(8):1927-32. PubMed ID: 21546603
[TBL] [Abstract][Full Text] [Related]
17. One-Hour Postload Hyperglycemia Confers Higher Risk of Hepatic Steatosis to HbA1c-Defined Prediabetic Subjects.
Fiorentino TV; Andreozzi F; Mannino GC; Pedace E; Perticone M; Sciacqua A; Perticone F; Sesti G
J Clin Endocrinol Metab; 2016 Nov; 101(11):4030-4038. PubMed ID: 27459528
[TBL] [Abstract][Full Text] [Related]
18. [Associations between metabolic syndrome and reduced lung function in young people].
Kovalkova NA; Ragino YI; Travnikova NY; Denisova DV; Shcherbakova LV; Voevoda MI
Ter Arkh; 2017; 89(10):54-61. PubMed ID: 29171471
[TBL] [Abstract][Full Text] [Related]
19. Association of low adiponectin levels with the metabolic syndrome--the Chennai Urban Rural Epidemiology Study (CURES-4).
Mohan V; Deepa R; Pradeepa R; Vimaleswaran KS; Mohan A; Velmurugan K; Radha V
Metabolism; 2005 Apr; 54(4):476-81. PubMed ID: 15798954
[TBL] [Abstract][Full Text] [Related]
20. Metabolic syndrome, hepatic steatosis, and cardiovascular risk in children.
Rutigliano I; Vinci R; De Filippo G; Mancini M; Stoppino L; d'Apolito M; Giardino I; Macarini L; Pettoello Mantovani M; Campanozzi A
Nutrition; 2017 Apr; 36():1-7. PubMed ID: 28336101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
